Last month, the Centers for Medicare & Medicaid Services began meeting with patients who use the 15 drugs it selected for the second round of Medicare price "negotiations" -- including ...

Pfizer and Arvinas' experimental treatment significantly extends progression-free survival in breast cancer patients with ...

New breast cancer drug vepdegestrant shows promising results in increasing survival rates for patients with ESR1 mutations.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Their stories are part of the folk history of the 21st century now. One a street predator, one a gentleman predator.

Secretary Chris Wright visited Lawrence Livermore National Laboratory (LLNL) on May 28, experiencing firsthand the ...

National Institutes of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

Bildnachweis: ITM Isotope Technologies Munich SE, VC Magazin, Pixabay. As the global demand for targeted cancer therapies ...